Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04515004).
- LEUKOIndependent statistical analysis of Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00147082).
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval,…
- LEVANT 2 Safety Registry: Complete Statistical AnalysisIndependent statistical analysis of LEVANT 2 Safety Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01790243).
- Levetiracetam 1000 mg Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam 1000 mg Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00859430).
- Levetiracetam 750 mg Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam 750 mg Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00849862).
- Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00141115).
- Levetiracetam in the Management of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam in the Management of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566150).
- Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03940326).
- LEVO-CTSIndependent statistical analysis of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- levobupiIndependent statistical analysis of Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01881087).
- Levocarnitine in Treating Fatigue in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Levocarnitine in Treating Fatigue in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00091169).
- Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing: Complete Statistical AnalysisIndependent statistical analysis of Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication: Complete Statistical AnalysisIndependent statistical analysis of Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02596620).
- Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lexapro and Pramipexole and to Treat Major Depression: Complete Statistical AnalysisIndependent statistical analysis of Lexapro and Pramipexole and to Treat Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00086307).
- LFMSIndependent statistical analysis of LFMS: Initial Trial in Geriatric Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02707276).
- LFQIndependent statistical analysis of Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04657523).
- LFTMSIndependent statistical analysis of Low Frequency TMS for Depression in Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03105700).
- LHONIndependent statistical analysis of Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LIBERATEIndependent statistical analysis of Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01796392).
- LIBERATE – LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: Complete Statistical AnalysisIndependent statistical analysis of LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03887650).
- LIBERTIIndependent statistical analysis of Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LIBERTYIndependent statistical analysis of Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855412).
- LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: Complete Statistical AnalysisIndependent statistical analysis of LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LIDIndependent statistical analysis of Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age: primary…
- LID in PDIndependent statistical analysis of Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lidocaine 04Independent statistical analysis of Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lidocaine Administration Using STAR Particles: Complete Statistical AnalysisIndependent statistical analysis of Lidocaine Administration Using STAR Particles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06034340).
- Lidocaine and Ketamine in Abdominal Surgery: Complete Statistical AnalysisIndependent statistical analysis of Lidocaine and Ketamine in Abdominal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721110).
- Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment: Complete Statistical AnalysisIndependent statistical analysis of Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00628355).
- LidoketofolIndependent statistical analysis of Recovery After Total Intravenous Anesthesia With Ketofol Versus Mixture of Ketofol and Lidocaine for Short Pediatric Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LIDSIndependent statistical analysis of A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LIFEIndependent statistical analysis of The LIFE Study - Lifestyle Interventions and Independence for Elders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01072500).
- Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care: Complete Statistical AnalysisIndependent statistical analysis of Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04316715).
- Lifeflight: Fentanyl Versus Morphine: Complete Statistical AnalysisIndependent statistical analysis of Lifeflight: Fentanyl Versus Morphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580489).
- LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: Complete Statistical AnalysisIndependent statistical analysis of LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01368406).
- Lifestyle Intervention in Preparation for Pregnancy (LIPP): Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention in Preparation for Pregnancy (LIPP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03146156).
- Lifestyle Modification and Lorcaserin for Weight Loss Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Modification and Lorcaserin for Weight Loss Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02388568).
- LIFUP PDIndependent statistical analysis of LIFUP for Treatment of Motor Deficits in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04593875).
- Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: Complete Statistical AnalysisIndependent statistical analysis of Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne: primary endpoint results, effect estimate with…
- Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03794908).
- Lighting Intervention for Cancer-related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Lighting Intervention for Cancer-related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827446).
- LiiRAIndependent statistical analysis of Lipids, Inflammation, and CV Risk in RA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02714881).
- Like Father Like Son: Complete Statistical AnalysisIndependent statistical analysis of Like Father Like Son: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04119414).
- Limberg-flap: Prospective Data Collection: Complete Statistical AnalysisIndependent statistical analysis of Limberg-flap: Prospective Data Collection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00672555).
- LIMITIndependent statistical analysis of Low Indexes of Metabolism - Information to Teams (LIMIT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02476578).